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1. Introduction 
 Cephalosporins are ┚- lactam antibiotics. In cephalosporin C, four membered ┚- lactam ring 
(which is mainly responsible for the activity) is fused with six membered dihydrothiazine 
ring to form the basic nucleus, 7-aminocephalosporanic acid (7-ACA) and to which ┙- 
aminoadipic acid side chain is attached through an amide bond (Fig 1). (Mandell and 
Sande,1991)Although cephalosporin was found to be active against large number of 
pathogenic bacteria (Medeiros, 1997) but the main hindrance in its application is its low 
stability. Also, occurrence of bacterial strains that are resistant to already existing antibiotics 
such as methicillin resistant Staphylococcus aureus (MRSA) and vancomycin resistant E. 
faecalis (VRE) has led to the search of new semisynthetic cephalosporins with better 
solubility and new mechanism of action. Only cephalosporin C is found naturally, so it’s 
chemical modification allowed production of a whole series of semisynthetic cephalosporins 
which can be used as therapeutics to fight organisms that have become penicillin resistant. 
Chemical modifications of cephalosporin C resulted in new cephalosporin derivatives. These 
semisynthetic cephalosporins are classified based on their activity profile, the antibacterial 
spectrum. Each newer generation of cephalosporin has significantly greater Gram –ve 
antimicrobial properties than the preceding generations, (Stan,2004; Jones,1994; Jacoby,2000; 
Babini and Livermore, 2000) in most cases with decreased activity against Gram +ve 
organism. Fourth generation cephalosporins are known to have true broad spectrum 
activity. (Wilson,1998; Tzouvelekis et al., 1998) In the past decade, even though the 
cephalosporin antibiotics have made remarkable progress and contribution in the treatment 
of acute diseases originated from pathogenic infection in clinics, many efforts still exist to 
achieve the well balanced broad spectrum and to improve beta-lactamase stability. 7┙-
formamido cephalosporins were isolated as fermentation product of various gram negative 
bacteria. The development of a new antibiotic focuses mainly with the study and 
characterization of its mechanism of its activity (Table 1). The ┚-lactam antibiotics like 
penicillin, cephalosporins, vancomycin, etc. are specific inhibitor working against bacterial 
cell wall (peptidoglycan) synthesis but newer strains have ┚-lactamase activity which 
destroys most of the ┚-lactam antibiotics and thus make them resistant to it. However, 
cephalosporins proved to be more stable to ┚-lactamase. Cephalosporin-C (CPC) shows 
similarity to in structure with the penicillin in having an acyl side chain attached to an 
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amino group of a double ring nucleus (Figure 1). The side chain was identical to that of 
penicillin N, i.e. D-┙-aminoadipic acid. Although both the types have the four membered ┚-
lactam group, cephalosporin-C have a six membered dihydrothiazine ring in place of the 
five membered thiazolidine ring system which is a characteristic of penicillins. But these 
antibiotics are not that effective to be used for clinical purposes. The cephalosporin nucleus, 7- 
aminocephalosporanic acid (7-ACA) is derived from cephalosporin-C, prove to be more 
effective. Modification of 7-ACA side chains resulted in the development of newer generations 
of useful antibiotic agents, which leaded to various generations of cephalosporins. 
 
Antibiotics Source Mode of action 
Antibacterial antibiotics  
Bacitracin Bacillus subtilis Cell-wall synthesis 
Cephalosporin Cephalosporium sp. Cell-wall synthesis 
Chloramphenicol Streptomyces venezuelae Protein synthesis 
Cycloserin Streptomyces leavendulae Cell-wall synthesis 
Erythromycin Streptomyces erythraeus Protein synthesis 
Kanamycin Streptomyces kanomycetoius Protein synthesis 
Neomycin Streptomyces fradiae Protein synthesis 
Novobiocin Streptomyces sp. DNA synthesis 
Penicillin Penicillium sp. Cell-wall synthesis 
Polymixin Bacillus polymyxa Cell membrane 
Streptomycin Streptomyces griseus Protein synthesis 
Tetracycline Streptomyces aureofaciens Protein synthesis 
Vancomycin Streptomyces orientalis Cell-wall synthesis 
Antiprotozoan antibiotics  
Fumagilin Aspergillus fumigatus Protein synthesis 
Antifungal antibiotics   
Amphotericin B Streptomyces nodosus Membrane function 
Cycloheximide Streptomyces griseus Protein synthesis 
Griseofulvin Penicillium griseofulvum Cell-wall, microtubules 
Nystatin Streptomyces noursei Damages cell-membrane 
Table 1. Different mode of activity/ action of major antibiotics. (Gaurav et al., 2011) 
The ┚-lactam antibiotics like penicillin, cephalosporins, vancomycin, etc. are specific inhibitor 
working against bacterial cell wall (peptidoglycan) synthesis but newer strains have ┚-
lactamase activity which destroys most of the ┚-lactam antibiotics and thus make them 
resistant to it. However, cephalosporins proved to be more stable to ┚-lactamase. 
Cephalosporin-C (CPC) shows similarity to in structure with the penicillins in having an acyl 
side chain attached to an amino group of a double ring nucleus (Figure 1). The side chain was 
identical to that of penicillin N, i.e. D-┙-aminoadipic acid. Although both the types have the 
four membered ┚-lactam group, cephalosporin-C have a six membered dihydrothiazine ring 
in place of the five membered thiazolidine ring system which is a characteristic of penicillins. 
But these antibiotics are not that effective to be used for clinical purposes. The cephalosporin 
nucleus, 7- aminocephalosporanic acid (7-ACA) is derived from cephalosporin-C, prove to be 
more effective. Modification of 7-ACA side chains resulted in the development of newer 
generations of useful antibiotic agents, which leaded to various generations of cephalosporins. 
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Fig. 1. The structure of Cephalosporin 
Cephalosporins are nowadays more suggested for the prophylaxis and treatment of 
bacterial infections caused by susceptible microorganisms. First generation cephalosporins 
are predominantly effective against gram positive bacteria and successive generations 
(Table 2) have further enhanced the activity against the gram negative bacteria too (Essack, 
2001) However, the synthesis of different generations of cephalosporins are only possible 
either by microbial routes or by enzymatically converting cephalosporin-C. Hence, a brief 
discussion on microbial synthesis of cephalosporin-C is quite needed.  
 
Various Generation Example 
First generation Cephalosporins Cephalothin 
Cephaloridine 
Cephazolin 
Cephradine 
Cefroxadine 
Second generation 
Cephalosporins 
Cephamandole 
Cefuroime 
Ceforanide 
Cefotiam 
Third generation Cephalosporins Cefotaxime 
Ceftazidime 
Ceftizoxime 
Ceftriaxone 
Cefixime 
Ceftibuten 
Fourth generation 
Cephalosporins 
Cefipime 
Cefpirome 
Table 2. Various Generations of Cephalosporin group of antibiotics 
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2. Microbial synthesis of cephalosporin-C  
The biosynthesis of cephalosporin-C is carried only by few microorganisms, viz. fungi, 
Streptomyces sp. and bacteria. It can produced by free and immobilized microbial cells 
(Kundu et al., 2000) using various cultivation modes of batch and continuous strategy 
(Mahapatra et al., 2002). In batch mode of fermentation, Cephalosporin-C is produced in 
stirred tank bioreactors (Srivastava et.al, 1996) as well as in air lift bioreactor (Srivastava et 
al., 1995; 1999).In continuous mode of fermentation, it can be produced both by packed bed 
bioreactor using different types of immobilization processes and in continuous stirred tank 
bioreactor. As it’s a highly aerobic process in nature, cephalosporin-C is also produced by 
immobilized microbial cells utilizing symbiotic mode (in-situ oxygen production) in a 
packed bed bioreactor. (Kundu et al., 1993)  
In order to fulfill the need of large quantity of semi-synthetic cephalosporin, the key 
intermediates should be produced in large quantity through very efficient and cheap 
production routes. But the chemical production of the intermediates generates large 
quantities of wastes and requires expensive and hazardous chemicals and reaction 
conditions. In order to overcome these problems, enzymes are used to perform the required 
reactions. Cephalosporin C is converted to 7-ACA in a two step enzymatic process. First the 
side chain is deaminated by a D-amino oxidase, resulting in an ┙-keto acid that 
spontaneously loses carbon dioxide in the presence of hydrogen peroxide to form glutaryl-7-
ACA. Subsequent enzymztic deacylation of the glutaryl side chain yields 7-ACA. The 
enzyme used, cephalosporin acylase, removes a charged aliphatic side chain without 
damaging the ┚- lactam nucleus. These enzymatic processes have the advantage of 
generating less waste and requiring less expensive chemicals. Thus, cephalosporin-C is 
directly converted to 7-ACA by cephalosporin-C acylase enzyme. (Zhang and Xu, 1993) 
2.1 Production strategy of cephalosporin C (primary precursor)  
Microbial production of Cephalosporin C, a secondary metabolite, occurs in late stationary 
phase (Idio-phase) of growth. So the main strategy of the production is to grow the culture 
to saturation level and then control the flow of nutrient to maintain the stationary phase. 
(Srivastava et al., 2006) Cephalosporin C fermentation always requires highly aerobic 
condition to maintain uniform yield. Hence, maximum focus is given on oxygenation of the 
media. There are different processes involved using various modes of bioreactors, viz. 
conventional and non conventional Bioreactors. The conventional mode of bioreactors 
involves in batch or continuous stirred tank bioreactors whereas non conventional mode 
involves in packed bed bioreactors, airlift bioreactors and the like. (Srivastava et al., 1996) 
2.1.1 Cephalosporin C production by conventional mode of bioreactors 
Conventional mode involves production by batch bioreactor or continuous stirred tank 
reactor (Kundu et al., 1993). Surface liquid culture and solid state fermentation are not very 
much favorable as there is high probability of oxygen limitation. There are some research 
occurring in the field but the stable process involved is the stirred tank batch bioreactors. 
They have special attachment for oxygen sparging and agitation for making the oxygen 
more available to microorganisms (Srivastava et al., 1996).The morphological characteristics 
of the mold change under high agitation which in turn affects the yield of the Cephalosporin 
C. (Kundu et al., 1993) 
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Continuous mode involves various continuous stirred tank bioreactors. The first type is 
where the oxygen is being sparged in the reactor fitted with an agitator (Figure 2 A). The 
second process involves addition of highly oxygenated media in the bioreactor (Figure 2 B). 
The continuous processes have advantages but there are several parameters which are to be 
maintained. Due to the microorganism, being filamentous and taking long time to reach 
stationary phase microorganism are first allowed to grow under batch condition and then 
continuous mode of operation is started. (Srivastava et al., 2006) 
 
Fig. 2. A) Continuous Bioreactor with oxygen Sparger B) Continuous Bioreactor with oxygen 
enriched fresh substrate 
2.1.2 Cephalosporin C production by Non conventional mode of bioreactors 
The non conventional mode involves in either Packed bed bioreactor or Airlift bioreactor. 
Various modes of immobilized microorganisms are used in packed bed reactors. The main 
advantage of packed bed reactor is that it can be operated in batch or continuous mode. The 
residence time and microorganism reusability is high in case of packed bed reactors. There 
are reported studies involving silk sachets for holding the immobilized beads with 
significant increase in production. (Kundu et al., 2000) 
Cephalosporin C fermentation is a highly aerobic process. The major problem which arises 
with aerobic fermentation are the mass transfer limitation of oxygen to immobilized cell. 
(Mishra et al., 2005) Even with addition of highly oxygenated media, the beads packed in 
depth doesn’t have enough oxygen to carry out cephalosporin C production, instead they 
produce Penicillin N, which is not desirable. There is a reported study where mixed culture 
technique for improving the oxygen supply to the immobilized cells. In such system, the 
products of metabolism of one microorganism are utilized by the second microorganism. 
Photoautotrophic algae (Chlorella sp.) which produce oxygen in situ are coupled with fungi 
(Cephalosporium acremonium) which in turn produce the Cephalosporin C. (Figure 3) (Kundu 
and Mahapatra, 1993; Kundu et al., 2003) The algae absorb CO2 from air and media 
producing free oxygen which not only removes the anaerobic condition prevailing in 
packed bed reactor but also adds up oxygen to the media. Co-immobilization of whole cells 
were reported to be carried out by using various immobilizing agents, viz. Bagasse, Silk 
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sachets, calcium/Barium/strontium alginate and the same coated with poly-acrylamide 
resin.  
 
Fig. 3. Packed Bed Reactor with Co-immobilized microbial cells (Algae and Fungi) for 
enhanced oxygenation 
Airlift Bioreactors are the most favorable reactors for production as it completely solve the 
oxygenation issue. There are two types of Airlift bioreactors. Internal air loop reactors have 
inner draft tube (Figure 4) while the external bioreactors have external tube as downcomer. 
They both have significant production values. (Srivastava and Kundu, 1999; Srivastava et al., 
1995)The air lift reactor ensures proper oxygenation and agitation. They are also gentle on 
filamentous fungi imparting low shear than any other conventional process agitator, 
improving production. Though, the process is costlier and tough but it ensures high 
cephalosporin C production. Figure 4 shows the airlift bioreactors involved in cephalosporin 
C production. The internal loop airlift reactors have better oxygenation and are preferred 
above external loop bioreactor.  
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Fig. 4. Internal air-loop reactor for Cephalosporin C production 
2.2 Production strategy of 7- amino cephalosporanic acid (secondary precursor) 
Biosynthesis of 7- Amino cephalosporanic acid (7-ACA) is an important process which 
involves the use of free and immobilized microbial cells. This can be single step or multi-
step microbial enzymatic process (Gaurav et al., 2007). There are lots of advantages of single 
step over the multi-step process (Nigam et al., 2005). Cephalosporin C acylase enzyme is 
involved in the conversion of Cephalosporin C to 7- ACA in single step mode of conversion. 
The microorganisms used for the synthesis of this enzyme are Pseudomonas diminuta, Bacillus 
megaterium and E. coli (Nigam and Kundu, 1999). There is also study on continuous 
production of 7-ACA by loading immobilized microbial cell in a packed bed bioreactor at 
optimum cells to carrier ratio and at an optimum flow rate (Nigam et al., 2005).  
3. Different generations Cephalosporins 
Cephalosporins can usually be classified into four different generations though newer 
generations are in active research, developed in response to a specific clinical need for a 
drug with different characteristics than the previous generation. Table 2 narrates the 
examples of various generation of Cephalosporins group of antibiotics. 
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3.1 First generation cephalosporins 
The first generation cephalosporins were first introduced in the mid-1960s and were stable 
to the ┚-lactamases known at that time. They permeated the outer membrane of gram-
negative bacilli quicker than the penicillins. The first generation drugs include Cephalothin, 
Cephaloridine and Cefazolin (Figure 5). Cephalothin was synthesized by biochemically 
using different processing strategies [Gaurav et.al., 2007]. Cephalexin and Cefeclor are both 
used as oral treatment drugs, and have broad activity against both gram-positive and gram-
negative microorganisms. However, they are inactive against Enterococci as they don’t bind 
well to PBPs of the Enterococci having slight difference.  
 
Fig. 5. First generation Cephalosporins 
3.2 Second generation cephalosporins 
The second generation cephalosporins have enhanced activity against gram-negative 
microorganisms (Livermore 1987; Stan et al., 2004). They are more stable to hydrolysis by 
plasmid-mediated ┚-lactamases when compared to cefoxitin, to the chromosomal class C 
cephalosporinase of several Enterobacteriaceae. (Medeiros 1997). The second generation 
cephalosporins include, Cefoxitin, Cefmetazole, Cefuroxime and Cefotetan (Figure 6). 
Cefuroxime is generally used for respiratory tract and community acquired infections. 
Cefoxitin has an extra methoxy-group that imparts protection against ┚-lactamase , but with 
an added disadvantage that it causes induction of the chromosomal ┚-lactamases in several 
bacterial organisms (which can be counterproductive). Cefoxitin (as well as Cefotetan) is 
well effective against Bacteroides fragilis, an enteric anaerobe but not against Pseudomonas or 
Enterobacter as it can’t enter them.  
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Fig. 6. Second generation Cephalosporins 
3.3 Third generation cephalosporins 
The third generation cephalosporins are less effective than the first generation cephalosporins 
against gram-positive cocci but are very much potent against Enterobacteriaceae, including the 
┚-lactamase-producing strains (Mandell & Sande 1991). The aminothiazolyl and 
iminomethoxy groups are the substituents in third generation cephalosporins (Neu 1986), 
which imparted greater stability against the chromosomal class C ┚-lactamases and with an 
increased spectrum of activity.These cephalosporins include Cefotaxime, Ceftizoxime and 
Ceftazidime (Figure 7). The drugs are broad spectrum antibiotics that are effective against both 
gram-negative and gram-positive microorganisms. The sodium salts of these antibiotics also 
showed a greater potential. 
Cefotaxime has an enhanced affinity to penicillin binding proteins (PBPs) of gram-negative 
bacteria and thus it could penetrate faster into bacterial cell as compared to older generation 
cephalosporins.  
Also, cefotaxime is the main intermediary in the synthesis of cefpodoxime proxetil, a third 
generation oral cephalosporin, introduced recently into medical practice (Durckheimer et al., 
1985; Reynolds 1989). Third-generation cephalosporins have a broad spectrum of antimicrobial 
activity including Gram-positive, Gram-negative, and selected anaerobic species. (Neu 1991).  
┚ -lactamase induction or resistant organism selections are an important issue, especially in 
nosocomial infections (Stratton et al., 1992). Third generation cephalosporins vary in their 
ability to induce ┚-lactamases, but none is as effective inducers as the cephamycins, clavams, 
or carbapenems The discovery of Klebsiella isolates resistant to oxyiminocephalosporins 
imparted more difficulties to ┚-lactam antibiotics mediated by extended-spectrum ┚-
lactamases (ESBLs). Mutation in the structural genes of plasmid-mediated TEM, SHV, and 
OXA ┚-lactamases and to a lesser extent in the PER and CTX enzymes enhanced their 
affinity for third generation cephalosporins and monobactams, but with varying degrees 
marking the pavement for newer generations. 
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Fig. 7. Third generation cephalosporins 
3.4 Fourth generation cephalosporins 
The fourth generation cephalosporins  contains a positively charged quaternary nitrogen 
atom at C-3, resulting in higher activity (compared to the third-generation cephalosporins) 
against ┚-lactamase derepressed mutants of P. areuginosa and other enteric bacteria 
(Georgopapdakau et al., 1989). The fourth generation cephalosporins, Cefepime, Cefpirome 
and Cefclidin (Figure 8) have the 7-amino-thiazolyl groups [(Livermore & Williams 1996). 
Cefepime have good potency against gram-negative organisms such as Pseudomonas 
aeruginosa, and gram-positive organism such as Staphylococcus aureus, also exhibiting 
increased stability against ┚-lactamase-overproducing bacteria. Cefepime is [6 R – [6 ┙, 7 ┚ 
(Z)]]-1-[[7-[[(2-amino-4-thiazolyl) (methoxyimino) acetyl] amino]-2-carboxy-8-oxo-5-thia-1-
azabicyclo oct-2-en-3yl] methyl]-1-methylpyrrolidinium inner salt. It is synthesized from 7-
aminocephalosporanic acid (7-ACA) with help of trimethylsilyl iodide and N-
methylpyrrolidine. It is stable to hydrolysis by the more common chromosomal and 
plasmid-mediated ┚-lactamases, and it is quite stable against inducible chromosomally 
mediated cephalosporinases  
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Fig. 8. Fourth generation Cephalosporins 
3.5 Fifth generation cephalosporins 
The fifth generation cephalosporin is still an unclear picture with many new modified 
cephalosporins in the research sector. This generation antibiotic is specifically developed 
against nosocomial infections of MRSA and Pseudomonas based refractory infection in 
immuno-compromised patients. Drugs which are in immediate attention of FDA are 
Ceftobiprole, LB10522 (Kim et al., 1996) and RU-59863 (Figure 9). Ceftobiprole specifically 
attacks by binding to this penicillin-resistant target. Interactions with cephalosporin side 
chains occurs in the groove, closed in the free PBP 2a enzyme, binds to the 7-acyl amino side 
chain, and in another extended groove where it interacts with the 3'-cephem side chain 
through noncovalent interactions (Lim & Strynadka 2002). It is stable to class A 
penicillinases produced by S. aureus and enteric gram-negative microorganisms and is more 
stable to few class C beta-lactamases of enteric gram-negative microorganisms (Hebeisen et 
al., 2001). 
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Fig. 9. Fifth generation Cephalosporins 
4. Current research in new generation cephalosporins 
It is also known that incorporation of a methoxy group in both cephalosporin and penicillin 
has led to a considerable increase in beta-lactamase stability. These findings prompted us to 
prepare methoxy and formamido derivatives of Cephalosporin and screen them for their 
antibacterial activity. 
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Our research team’s current work is to attempt synthesizing some new semi-synthetic 
cephalosporins and some by modifying already existing semi-synthetic cephalosporins such 
as cefotaxime (third generation). It is broad spectrum antibiotic with high resistance against 
beta-lactamases. But the main problem is that it is poorly soluble in water. Hence, the efforts 
have been made to prepare cephalosporins having better solubility using cefotaxime. All 
these semi-synthetic cephalosporins are derived from the key intermediate 7- ACA, a 
product derived from cephalosporin C hydrolysis. They differ in the nature of the substitute 
attached at the 3 and/ or 7- position of the cephem ring and express various biological and 
pharmacological effects. 
In the present work, enzymatic method has been employed to produce 7-ACA, the key 
intermediate and this 7-ACA is then utilized for the synthesis of new semi-synthetic 
cephalosporins. Nicotinic acid, benzimidazole, imidazole or substituted benzimidazole system 
has been shown to have different pharmacological effects including antifungal, antibacterial 
and antiviral effects. 2-substituted benzimidazoles, with various types of biological activity, 
have a close relationship to nucleic acid metabolism. Hence, semi-synthetic cephalosporins 
containing these nucleuses were prepared and the assessment of these molecules has been 
checked to interfere with various cellular and metabolic processes. (Figure 10) 
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Fig. 10. Formation of new generation Cephalosporins. 
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In a search for unique and potent cephalosporin antibiotics, we have prepared new semi-
synthetic cephalosporins. The motivation for synthesizing these semi-synthetic 
cephalosporins was to increase the availability of drug at the target site and their oral 
absorptivity and increased stability. Thus, recurring need for an easily cleaved blocking 
group for the carboxylic acid in the cephalosporin synthetic chemistry forms the basis of the 
research. All the synthesised cephalosporins were having easily hydrolysable esters for oral 
absorption studies; they were also having such suitable blocking groups for the carboxyl, 
which might be removed later without disruption of the beta-lactam ring. Although simple 
esters, like the methyl ester, are known to possess diminished antibiotic activity compared 
to the free acids, the possibility exists that more easily hydrolysable esters (by enzymatic or 
chemical means) might exhibit significant in vivo activity. A therapeutic advantage might be 
anticipated from derived compounds if the structural environment of the carboxyl group is 
a bar to absorption through the gastric or intestinal walls. Activity could be inherent in the 
derivative or be produced a result of enzymatic cleavage to the parent compound after 
absorption has occurred. Gastric acidity, often a negative influence in oral absorptibility of 
penicillins, would send to be an unlikely factor in cephalosporin absorption because of the 
relatively good acid stability of this class of antibiotics. For the synthesis of these analogues, 
the methods that are of general applicability are used. To form peptides from a 
cephalosporin required that the carboxyl at C-4 be appropriately activated for acylation of a 
protected amino acid. In synthetic organic chemistry, compound containing the 
carbodiimide functionality are dehydrating agents and are often used to activate carboxylic 
acids towards amide or ester formation. Additives, such as N-hydroxybenzotriazole are 
often added to increase yields and decrease side reactions. EDC (acronym for 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride) is a water soluble carbodiimide which 
is used as a carboxyl activating agent for the coupling of primary amines to yield amide 
bonds. The possibility that amides derived from a cephalosporanic acid and an amino acid 
might cross the intestinal wall and be cleaved in the body.  
5. Conclusion 
In general, attempts to modify the ┚- lactam thiazolidine ring system of penicillin without loss 
of antibacterial activity had been unsuccessful. The discovery, structure elucidation and 
modification of cephalosporin C, which led to important new generations of Cephalosporin 
group of antibiotics and its large scale production and marketing. In the past decade, even 
though cephalosporin antibiotics have made remarkable progress and contribution in the 
treatment of acute disease, many efforts still exist to achieve the well-balanced broad-spectrum 
and to improve beta-lactamases stability. This work, lead to highly active, acid stable, 
penicillin resistant, nontoxic antibiotic with increased potency against a wide range of bacteria. 
Although the progress is in preliminary stage but significance of the work is enormous.  
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